Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute cholestatic hepatitis during simvastatin administration.

M Ballaré1, M Campanini, E Catania

  • 1Divisione di Medicina generale II, Ospedale Maggiore, Novara.

Recenti Progressi in Medicina
|April 1, 1991
PubMed
Summary

Simvastatin can cause liver damage, specifically acute cholestatic hepatitis, through an immune response. Monitoring liver function is crucial during statin therapy to detect and manage potential adverse effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study.

The Journal of small animal practice·2025
Same author

Management of Hypothyroidism in Internal Medicine: Patient Profile and Effects of an Educational Programme in the Cluster-Randomized FADOI TIAMO Study.

Frontiers in endocrinology·2022
Same author

Diabetes and CoViD-19: Experience from the frontline of Internal Medicine wards in Italy.

Diabetes research and clinical practice·2020
Same author

Hospitalization and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD): an Italian population-based study.

European review for medical and pharmacological sciences·2020
Same author

The ultrathin limit of improper ferroelectricity.

Nature communications·2019
Same author

Depolarizing-Field Effects in Epitaxial Capacitor Heterostructures.

Physical review letters·2019

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Immunology

Background:

  • Simvastatin is a widely prescribed statin for hypercholesterolemia.
  • Elevated serum transaminases are known potential side effects of simvastatin therapy.
  • The underlying mechanism of simvastatin-induced liver injury requires further elucidation.

Observation:

  • A case of acute cholestatic hepatitis developed during simvastatin treatment.
  • Clinical, biochemical, immunological, and histological data supported the diagnosis.
  • The presentation suggested an immune-mediated liver damage.

Findings:

  • Simvastatin therapy was associated with acute cholestatic hepatitis.
  • Evidence pointed towards an immunological mechanism in the liver injury.

Related Experiment Videos

  • The liver damage was characterized by specific clinical and biochemical markers.

    • Implications:

    • Healthcare providers should monitor liver function tests in patients receiving simvastatin.
    • Caution is advised when continuing simvastatin if transaminase levels rise.
    • This case highlights the importance of recognizing drug-induced liver injury, particularly immune-mediated hepatotoxicity.